Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

Dear Crypto Fans, Watch CND Stock and the New Circle SPAC Merger

By Robert Lakin, InvestorPlace Contributor

Stablecoin USDC issuer Circle recently raised $440 million. Now it's set to become publicly traded in a SPAC merger with Concord Acquisition.

CARV Stock: Why Retail Investors Are Betting Big on a Squeeze for Carver Bancorp

By Robert Lakin, InvestorPlace Contributor

Shares of Carver Bancorp surged following a report on high short interest. While it's one of the country's biggest Black-owned banks, CARV stock's market cap is too small for the r/WallStreetBets crowd.

Ethereum Crypto News: What Is the Big Catalyst for Ethereum Prices on August 4?

By Robert Lakin, InvestorPlace Contributor

The architecture under Ethereum crypto is set to see some changes with the reveal of the so-called "London hard fork" now expected on Aug. 4. Ethereum prices have gain more than 10% in the past week.

CLOV Stock: The News That Should Have Clover Health Fans Cheering

By Robert Lakin, InvestorPlace Contributor

An SPAC merger, Clover Health is an AI-fueled provider of Medicare Advantage plans. CLOV stock could gain after announcing a new grocery benefit for members.

DIDI Stock: The Huge News That Has Didi Plunging Days After Its IPO

By Robert Lakin, InvestorPlace Contributor

Just days after its ADRs listed in the U.S., Didi stock is getting pummeled after a Beijing watchdog blocked downloads of ride-hailing app on "cybersecurity concerns."

OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today

By Robert Lakin, InvestorPlace Contributor

Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials. OCGN stock has been on a roller-coaster ride on every Covaxin rumor and news item.

DNUT Stock: What to Know as Krispy Kreme Starts Trading Today

By Robert Lakin, InvestorPlace Contributor

From your waistline to the bottom line, Krispy Kreme is back on Wall Street. The IPO priced below expectations as DNUT stock is set to debut today.

Chinese EV Stocks: Why LI, XPEV, NIO Stocks Are Revving Up Today

By Robert Lakin, InvestorPlace Contributor

Chinese EV makers are reporting record deliveries for June and Q2 despite a chip shortage. Nio and Xpeng both reported triple-digit percentage increases in units delivered.

SRAC Stock: Why Stable Road Is Gaining Ahead of a Momentus SPAC Merger

By Robert Lakin, InvestorPlace Contributor

SPAC sponsor Stable Road Acquisition is getting more time to complete the SRAC stock merger with space cargo hauler Momentus.

XELA Stock: The Big News That Has Exela Technologies Continuing to Soar

By Robert Lakin, InvestorPlace Contributor

XELA stock is up another 50% in Wednesday morning trading as Exela benefits from short-squeeze hopes and company updates.

Load More